CABA vs PEP · $143.9M cap vs P/E 22, rev $93.92B
Cabaletta Bio Inc (CABA) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
CABA does not have a complete income-statement cache yet.
Latest reported PEP revenue for 2025-12-27 was $93.92B. Net income was $8.24B. Revenue was up 2.3% from 2024-12-28 to 2025-12-27. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
CABA currently screens at market cap $143.9M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the CABA and PEP stock pages for the full models.
Not investment advice.